nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.159	0.159	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.114	0.114	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0432	0.0432	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0419	0.0419	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0273	0.0273	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0262	0.0262	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0254	0.0254	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0237	0.0237	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0224	0.0224	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0218	0.0218	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0215	0.0215	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0203	0.0203	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0192	0.0192	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0188	0.0188	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0182	0.0182	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0171	0.0171	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.017	0.017	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0161	0.0161	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0156	0.0156	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0154	0.0154	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0145	0.0145	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0142	0.0142	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0137	0.0137	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0122	0.0122	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0119	0.0119	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0119	0.0119	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0111	0.0111	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0108	0.0108	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0102	0.0102	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00966	0.00966	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00938	0.00938	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00877	0.00877	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00874	0.00874	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00852	0.00852	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00793	0.00793	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00775	0.00775	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00691	0.00691	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00671	0.00671	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00628	0.00628	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00625	0.00625	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00612	0.00612	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00609	0.00609	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00568	0.00568	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00556	0.00556	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00518	0.00518	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00503	0.00503	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00469	0.00469	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00438	0.00438	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00398	0.00398	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00371	0.00371	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0036	0.0036	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00335	0.00335	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00328	0.00328	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.00277	0.00277	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.00252	0.00252	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00235	0.00235	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
